Latest News for: sigyn

Edit

Annual Report for Fiscal Year Ending December 31, 2024 (Form 10-K) (Sigyn Therapeutics Inc)

Public Technologies 15 Apr 2025
Sigyn Therapeutics, Inc. ("Sigyn", the "Company", "we," "us," or "our") is a development-stage company focused on creating therapeutic solutions that address unmet needs in global healthcare.
Edit

Late Filing Notice (Form NT 10-K) (Sigyn Therapeutics Inc)

Public Technologies 31 Mar 2025
) OMB APPROVAL. UNITED STATES. SECURITIES AND EXCHANGE COMMISSION. Washington, D.C. 20549 OMB Number. 3235-0058. Expires. April 30, 2025. Estimated average burden hours per response 2.50 ... Sigyn Therapeutics, Inc ... SIGYN THERAPEUTICS, INC ... Sigyn Therapeutics Inc.
  • 1
×